Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Finasteride may help some women with hair loss, but better options exist.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Minoxidil dissolves better in propylene glycol + water than in supercritical CO2.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Suppressing certain hormones might help prevent prostate cancer.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Finasteride safely reduces excessive hair growth in women.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.